197 related articles for article (PubMed ID: 4946757)
21. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.
Abramson E; Arky RA
Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062
[No Abstract] [Full Text] [Related]
22. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
Kilo C; Miller JP; Williamson JR
Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
[No Abstract] [Full Text] [Related]
23. [Differential therapy using oral antidiabetics].
Mehnert H
Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
[No Abstract] [Full Text] [Related]
24. [Oral hypoglycaemic agents and cardiovascular deaths in diabetes].
Drury MI; Timoney FJ
Acta Diabetol Lat; 1972; 9(4):645-50. PubMed ID: 4657695
[No Abstract] [Full Text] [Related]
25. Long-term results with oral hypoglycemic drugs.
Moss JM; DeLawter DE
J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111
[No Abstract] [Full Text] [Related]
26. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
Cornfield J
JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
[No Abstract] [Full Text] [Related]
27. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
Gray RH
Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
[No Abstract] [Full Text] [Related]
28. Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
Goetz FC
Postgrad Med; 1972 Jul; 52(1):63-8. PubMed ID: 5067890
[No Abstract] [Full Text] [Related]
29. Insulin-independent diabetes mellitus.
Bricker LA; Mintz DH
Med Clin North Am; 1971 Mar; 55(2):295-304. PubMed ID: 4926053
[No Abstract] [Full Text] [Related]
30. Current unsolved problems in diabetes management.
Fajans SS
Diabetes; 1972; 21(2 Suppl):678-84. PubMed ID: 5054334
[No Abstract] [Full Text] [Related]
31. [Considerations on diabetic angiopathies. Relations to hypoglycemic treatments].
Lubetzki J
Nouv Presse Med; 1972 Mar; 1(11):715-8. PubMed ID: 5022249
[No Abstract] [Full Text] [Related]
32. Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
Kudzma DJ; Friedberg SJ
Diabetes; 1977 Apr; 26(4):291-5. PubMed ID: 321288
[TBL] [Abstract][Full Text] [Related]
33. Metabolic control of diabetes mellitus during routine management at an out-patient department.
Karlander SG; Alinder I; Hellström K
Acta Med Scand; 1980; 207(6):475-81. PubMed ID: 7001857
[No Abstract] [Full Text] [Related]
34. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics.
Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS
Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835
[TBL] [Abstract][Full Text] [Related]
35. Phenformin and vascular complications of diabetes.
Med Lett Drugs Ther; 1972 Jan; 14(1):1-2. PubMed ID: 4567560
[No Abstract] [Full Text] [Related]
36. [Practice guidelines review: Diabetes mellitus].
Noda M; Kadowaki T
Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1240-9. PubMed ID: 12056023
[No Abstract] [Full Text] [Related]
37. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
MOSS JM; DELAWTER DE; GALLAGHER EJ
Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
[No Abstract] [Full Text] [Related]
38. Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous?
Constam GR
Diabetologia; 1971 Aug; 7(4):237-9. PubMed ID: 5093706
[No Abstract] [Full Text] [Related]
39. Vascular disease in diabetes and the effect of oral antidiabetic agents.
Marble A
Adv Metab Disord; 1973; 2():Suppl 2:539-47. PubMed ID: 4720384
[No Abstract] [Full Text] [Related]
40. Antidiabetic agents and vascular events.
Keen H
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
